Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

Most Americans have COVID-19 antibodies as case numbers rise - Roll Call

The percentage of people with antibodies increased from 34 percent in December to roughly 58 percent in February, the CDC said.

Roll Call

Moderna Whale Trades For April 26

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

How Robert Langer, a pioneer in delivering mRNA into the body, failed repeatedly but kept going: 'They said I should give up, but I don't like to give up'

The mRNA vaccines developed against COVID-19 owe a lot to the work of Robert Langer, a pioneer in the delivery of mRNA. Langer, who is the Massachusetts Institute of Technology David H. Koch Institute Professor and director of the Langer Lab, helped lay the foundation for the underlying delivery mechanism…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Pass urgent COVID funding or more will die, White House says

After two years at the front of the line for COVID-19 vaccines and treatments, the U.S. could soon have to begin taking a number

The Independent UK

Poland, Moderna Working Towards Increased Flexibility Of COVID-19 Vaccine Contracts: Reuters

Poland can compromise with Moderna Inc (NASDAQ:MRNA) on increasing the flexibility of COVID-19 vaccine contracts, Reuters reported citing the health minister, striking an upbeat tone after initial talks with the company. Poland has said it will not take or pay for more doses of the COVID-19 vaccine under the European Union's supply contract. Reuters…

Benzinga

What's Going On With Moderna Shares?

Shares of vaccine companies, including Moderna Inc (NASDAQ: MRNA), are trading higher amid COVID-19 concerns due to rising cases in China.

Benzinga

This Is What Whales Are Betting On Moderna

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Computer modelling to aid search for HIV vaccine

The hunt continues at a brisk pace thanks to rapid developments in generating more potent computing power, writes Kumitaa Theva Das in part three in a series on vaccines beyond Covid.

Newsroom.co.nz

US can manage BA.2 variant ‘without disruption’, top Covid adviser predicts

Ashish Jha says spreading variant unlikely to have much effect on the nation’s pandemic recovery

The Guardian - US

COVID shots still work but researchers hunt new improvements

COVID-19 vaccines still offer strong protection against severe illness and death, but Moderna and Pfizer are testing combination shots as a possible new kind of booster

The Independent UK

Latest data shows significant rise in Covid deaths in England and Wales for third week in a row

Deaths involving Covid-19 are up 13 per cent on last week, the latest data shows

Manchester Evening News

Covid booster gives long-lasting protection, study finds

'The longer-term protection against hospitalisation and death is perhaps the most important factor for future booster programmes'

Wales Online

Third Covid-19 vaccine dose offers ‘prolonged immune response’ – UK-wide study

The study compared immune responses to seven vaccines used as a booster 28 days after two initial doses.

The Independent UK

If You Invested $1,000 In Moderna Stock At Its Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

Parents of kids under 5 still waiting for COVID shots

The demise of the federal transportation mask mandate was particularly jarring for many parents of children under five anxiously waiting for word on when COVID shots will become available to their kids.

Tribune News Service

Moderna says redesigned COVID-19 vaccine booster may work better against variants

Moderna’s updated COVID-19 booster shot shows even more efficiency against variants, the pharmaceutical company announced Tuesday, citing preliminary results from a trial.

360info

Computer modelling to aid search for HIV vaccine

The search continues at a brisk pace thanks to rapid developments in generating more potent computing power.

Benzinga

Moderna Says Dual Variant COVID-19 Booster With Beta is Better Effective Against Omicron Than Current Jab

Moderna Inc (NASDAQ:MRNA) said a COVID-19 booster designed to target the Beta variant and the original coronavirus generated a better immune response against several virus variants, including Omicron. Moderna said the results were a good sign for the company's plans for future shots targeting two COVID-19 variants. The company said the bivalent…

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Moderna announces step toward updating COVID shots for fall

Moderna hopes to offer updated COVID-19 boosters in the fall that combine the original vaccine with protection against the latest variant

The Independent UK

J&J suspends COVID-19 vaccine sales forecast

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year

Asharq Al-Awsat

Moderna Says Dual Variant Booster with Beta More Effective vs. Omicron than Current Shot

Moderna Inc on Tuesday said a COVID-19 booster designed to target the Beta variant as well as the original coronavirus generated a better immune response against a number of virus variants including Omicron. Moderna said the results were a good sign for the company's plans for future shots targeting two…

Daily Record

Scientists developing 'blockbuster' heart attack cure using Covid vaccine tech

Researchers from King's College London are working on regenerating damaged hearts in the hope of developing a cure for heart attacks - with human trials set to begin within two years.

Benzinga

What Are Whales Doing With Moderna

Someone with a lot of money to spend has taken a bullish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Britain Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years

Britain's medicines regulator approved the use of Moderna Inc's (NASDAQ:MRNA) COVID-19 vaccine in children between six and 11 years. The Medicines and Healthcare products Regulatory Agency (MHRA) said the approval was granted after Moderna's vaccine, known as Spikevax, met the required safety, quality, and effectiveness standards. Read Next: Why Did Moderna Recall Thousands Of COVID-19…

Daily Record

Moderna Covid vaccine approved in UK children's jabs for ages six to 11

The vaccine's rollout still depends on the verdict of the Joint Committee on Vaccination Immunisation.

1 … 26 27 28 29

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.